Clinical trials
Completed Lupus Erythematosus, Systemic trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 5 |
| 2016 | 6 |
| 2017 | 9 |
| 2018 | 9 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 3 |
| 2022 | 12 |
| 2023 | 3 |
| 2024 | 7 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 96 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 6 |
| Universitas Sriwijaya | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Brigham and Women's Hospital | 3 |
| Cairo University | 3 |
| Medical University of South Carolina | 3 |
| CHU de Reims | 2 |
| Centre Hospitalier Universitaire, Amiens | 2 |
| Johns Hopkins University | 2 |
| National Center for Research Resources (NCRR) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 96 |
| Fatigue | 9 |
| Arthritis | 7 |
| Arthritis, Rheumatoid | 7 |
| Autoimmune Diseases | 6 |
| Pain | 6 |
| Connective Tissue Diseases | 4 |
| Immune System Diseases | 4 |
| Lupus Nephritis | 4 |
| Scleroderma, Systemic | 4 |
Trials
Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.